Literature DB >> 27957170

Left Atrial Appendage Thrombus Resolution with Reduced Dose Apixaban.

Beatriz Vaquerizo1, Magdi Sami1.   

Abstract

A 63 year old woman with a history of persistent atrial fibrillation and CHADSVASC score of 2, suffered a massive stroke with a hemorrhagic transformation, 2 days following an appendectomy and reversal of warfarin anticoagulation with vitamin K. A left atrial appendage occlusive device (LAAOD) was considered for stroke prevention given the risk of recurrent cerebral hemorrhage. A transesophageal echocardiography (TEE) however, revealed left atrial appendage (LAA) clots which precluded the use of a LAAOD. A computed tomography revealed only partial resolution of the right hemispheric hematoma. Apixaban 2.5 mg twice daily was successful in resolving the LAA clots within 2 months without aggravating her cerebral hematoma which continued to resolve. This is the first case, to our knowledge showing reduced-dose Apixaban to completely resolve left atrial thrombus. Our case also addresses the issue of bridging following reversal of warfarin anticoagulation with vitamin K.

Entities:  

Year:  2015        PMID: 27957170      PMCID: PMC5135109          DOI: 10.4022/jafib.1182

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  10 in total

Review 1.  Bridging anticoagulation: is it needed when warfarin is interrupted around the time of a surgery or procedure?

Authors: 
Journal:  Circulation       Date:  2012-03-27       Impact factor: 29.690

2.  Resolution of giant left atrial appendage thrombus with rivaroxaban.

Authors:  Christoph Hammerstingl; Berndt Pötzsch; Georg Nickenig
Journal:  Thromb Haemost       Date:  2013-01-24       Impact factor: 5.249

Review 3.  Echocardiographic assessment of the left atrial appendage.

Authors:  Y Agmon; B K Khandheria; F Gentile; J B Seward
Journal:  J Am Coll Cardiol       Date:  1999-12       Impact factor: 24.094

Review 4.  New oral anticoagulants: comparative pharmacology with vitamin K antagonists.

Authors:  Francesco Scaglione
Journal:  Clin Pharmacokinet       Date:  2013-02       Impact factor: 6.447

5.  Clinical and echocardiographic characteristics of patients with left atrial thrombus and sinus rhythm: experience in 20 643 consecutive transesophageal echocardiographic examinations.

Authors:  Yoram Agmon; Bijoy K Khandheria; Federico Gentile; James B Seward
Journal:  Circulation       Date:  2002-01-01       Impact factor: 29.690

6.  Use of apixaban for an elderly patient with left atrial thrombus.

Authors:  Shintaro Dobashi; Tadashi Fujino; Takanori Ikeda
Journal:  BMJ Case Rep       Date:  2014-06-24

Review 7.  Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates.

Authors:  Deborah Siegal; Jovana Yudin; Scott Kaatz; James D Douketis; Wendy Lim; Alex C Spyropoulos
Journal:  Circulation       Date:  2012-08-21       Impact factor: 29.690

8.  Safety of switching from vitamin K antagonists to dabigatran or rivaroxaban in daily care--results from the Dresden NOAC registry.

Authors:  Jan Beyer-Westendorf; Vera Gelbricht; Kati Förster; Franziska Ebertz; Denise Röllig; Thomas Schreier; Luise Tittl; Christoph Thieme; Ulrike Hänsel; Christina Köhler; Sebastian Werth; Eberhard Kuhlisch; Thoralf Stange; Ingolf Röder; Norbert Weiss
Journal:  Br J Clin Pharmacol       Date:  2014-10       Impact factor: 4.335

9.  Resolution of left atrial appendage thrombus with apixaban.

Authors:  Tohru Kawakami; Hiroko Kobayakawa; Hiroyoshi Ohno; Nobukiyo Tanaka; Hiroki Ishihara
Journal:  Thromb J       Date:  2013-12-20

10.  Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial.

Authors:  Sigrun Halvorsen; Dan Atar; Hongqiu Yang; Raffaele De Caterina; Cetin Erol; David Garcia; Christopher B Granger; Michael Hanna; Claes Held; Steen Husted; Elaine M Hylek; Petr Jansky; Renato D Lopes; Witold Ruzyllo; Laine Thomas; Lars Wallentin
Journal:  Eur Heart J       Date:  2014-02-20       Impact factor: 29.983

  10 in total
  1 in total

Review 1.  Non-vitamin K antagonist oral anticoagulants for the treatment of intracardiac thrombosis.

Authors:  Eiman Ghaffarpasand; Maneli D Tehrani; Jolanta Marszalek; Gerald Chi
Journal:  J Thromb Thrombolysis       Date:  2018-10       Impact factor: 2.300

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.